ArticleESMO gastrointestinal oncology2024
Benefits from early trial involvement in metastatic colorectal cancer: outcomes from the phase I unit at the Sarah Cannon Research Institute UK.
R Woodford et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.